Cargando…

Nutritional Risk Screening in Cancer Patients: The First Step Toward Better Clinical Outcome

Disease-related malnutrition is highly prevalent among cancer patients, with 40–80% suffering from it during the course of their disease. Malnutrition is associated with numerous negative outcomes such as: longer hospital stays, increased morbidity and mortality rates, delayed wound healing, as well...

Descripción completa

Detalles Bibliográficos
Autores principales: Reber, Emilie, Schönenberger, Katja A., Vasiloglou, Maria F., Stanga, Zeno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058175/
https://www.ncbi.nlm.nih.gov/pubmed/33898493
http://dx.doi.org/10.3389/fnut.2021.603936
_version_ 1783680976478535680
author Reber, Emilie
Schönenberger, Katja A.
Vasiloglou, Maria F.
Stanga, Zeno
author_facet Reber, Emilie
Schönenberger, Katja A.
Vasiloglou, Maria F.
Stanga, Zeno
author_sort Reber, Emilie
collection PubMed
description Disease-related malnutrition is highly prevalent among cancer patients, with 40–80% suffering from it during the course of their disease. Malnutrition is associated with numerous negative outcomes such as: longer hospital stays, increased morbidity and mortality rates, delayed wound healing, as well as decreased muscle function, autonomy and quality of life. In cancer patients, malnutrition negatively affects treatment tolerance (including anti-cancer drugs, surgery, chemo- and radiotherapy), increases side effects, causes adverse reactions, treatment interruptions, postoperative complications and higher readmission rates. Conversely, anti-cancer treatments are also known to affect body composition and impair nutritional status. Tailoring early nutritional therapy to patients' needs has been shown to prevent, treat and limit the negative consequences of malnutrition and is likely to improve overall prognosis. As the optimisation of treatment outcomes is top priority and evidence for nutritional therapy is growing, it is increasingly recognized as a significant intervention and an autonomous component of multimodal cancer care. The proactive implementation of nutritional screening and assessment is essential for patients suffering from cancer - given the interaction of clinical, metabolic, pharmacological factors with systemic inflammation; and suppressed appetite with accelerated muscle protein catabolism. At the same time, a nutritional care plan must be established, and adequate individualized nutritional intervention started rapidly. Screening tools for nutritional risk should be validated, standardized, non-invasive, quick and easy-to-use in daily clinical practice. Such tools must be able to identify patients who are already malnourished, as well as those at risk for malnutrition, in order to prevent or treat malnutrition and reduce negative outcomes. This review investigates the predictive value of commonly used screening tools, as well as the sensitivity and specificity of their individual components for improving clinical outcomes in oncologic populations. Healthcare professionals' awareness of malnutrition in cancer patients and the pertinence of early nutritional screening must be raised in order to plan the best possible intervention and follow-up during the patients' ordeal with the disease.
format Online
Article
Text
id pubmed-8058175
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80581752021-04-22 Nutritional Risk Screening in Cancer Patients: The First Step Toward Better Clinical Outcome Reber, Emilie Schönenberger, Katja A. Vasiloglou, Maria F. Stanga, Zeno Front Nutr Nutrition Disease-related malnutrition is highly prevalent among cancer patients, with 40–80% suffering from it during the course of their disease. Malnutrition is associated with numerous negative outcomes such as: longer hospital stays, increased morbidity and mortality rates, delayed wound healing, as well as decreased muscle function, autonomy and quality of life. In cancer patients, malnutrition negatively affects treatment tolerance (including anti-cancer drugs, surgery, chemo- and radiotherapy), increases side effects, causes adverse reactions, treatment interruptions, postoperative complications and higher readmission rates. Conversely, anti-cancer treatments are also known to affect body composition and impair nutritional status. Tailoring early nutritional therapy to patients' needs has been shown to prevent, treat and limit the negative consequences of malnutrition and is likely to improve overall prognosis. As the optimisation of treatment outcomes is top priority and evidence for nutritional therapy is growing, it is increasingly recognized as a significant intervention and an autonomous component of multimodal cancer care. The proactive implementation of nutritional screening and assessment is essential for patients suffering from cancer - given the interaction of clinical, metabolic, pharmacological factors with systemic inflammation; and suppressed appetite with accelerated muscle protein catabolism. At the same time, a nutritional care plan must be established, and adequate individualized nutritional intervention started rapidly. Screening tools for nutritional risk should be validated, standardized, non-invasive, quick and easy-to-use in daily clinical practice. Such tools must be able to identify patients who are already malnourished, as well as those at risk for malnutrition, in order to prevent or treat malnutrition and reduce negative outcomes. This review investigates the predictive value of commonly used screening tools, as well as the sensitivity and specificity of their individual components for improving clinical outcomes in oncologic populations. Healthcare professionals' awareness of malnutrition in cancer patients and the pertinence of early nutritional screening must be raised in order to plan the best possible intervention and follow-up during the patients' ordeal with the disease. Frontiers Media S.A. 2021-04-07 /pmc/articles/PMC8058175/ /pubmed/33898493 http://dx.doi.org/10.3389/fnut.2021.603936 Text en Copyright © 2021 Reber, Schönenberger, Vasiloglou and Stanga. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Nutrition
Reber, Emilie
Schönenberger, Katja A.
Vasiloglou, Maria F.
Stanga, Zeno
Nutritional Risk Screening in Cancer Patients: The First Step Toward Better Clinical Outcome
title Nutritional Risk Screening in Cancer Patients: The First Step Toward Better Clinical Outcome
title_full Nutritional Risk Screening in Cancer Patients: The First Step Toward Better Clinical Outcome
title_fullStr Nutritional Risk Screening in Cancer Patients: The First Step Toward Better Clinical Outcome
title_full_unstemmed Nutritional Risk Screening in Cancer Patients: The First Step Toward Better Clinical Outcome
title_short Nutritional Risk Screening in Cancer Patients: The First Step Toward Better Clinical Outcome
title_sort nutritional risk screening in cancer patients: the first step toward better clinical outcome
topic Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058175/
https://www.ncbi.nlm.nih.gov/pubmed/33898493
http://dx.doi.org/10.3389/fnut.2021.603936
work_keys_str_mv AT reberemilie nutritionalriskscreeningincancerpatientsthefirststeptowardbetterclinicaloutcome
AT schonenbergerkatjaa nutritionalriskscreeningincancerpatientsthefirststeptowardbetterclinicaloutcome
AT vasilogloumariaf nutritionalriskscreeningincancerpatientsthefirststeptowardbetterclinicaloutcome
AT stangazeno nutritionalriskscreeningincancerpatientsthefirststeptowardbetterclinicaloutcome